Dr. Brian Nahed, MD

• Neurosurgery

• Neurological Skull Base Surgery

• Neurological Trauma Surgery

• Cancer Research

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Harvard Program In Clinical Effectiveness

  2012

• Harvard School Of Public Health

  2012

• New England Baptist Hospital

  Fellowship Hospital, 2012

• Department Of Neurosurgery, Massachusetts General Hospital, Harvard Medical School

  Residency Hospital, 2011

• Massachusetts General Hospital

  Residency Hospital, 2011

• Mgh Cancer Center Fellowship

  2010

• Massachusetts General Hospital, Harvard Medical School

  Internship Hospital, 2006

• Yale School Of Medicine

  Medical School, 2005

• Yale University

  Medical School, 2005

• University Of California At Los Angeles

  Undergraduate School, 2000

• Retrievable stent thrombectomy in the treatment of acute ischemic stroke: Analysis of a revolutionizing treatment technique, 2013-08-09

• Sporadic hemangioblastomas are characterized by crypticVHLinactivation, 2014-12-24

• Conflict of Interest in Spine Research Reporting, 2012-08-31

• Microenvironmental landscape of human melanoma brain metastases in response to immune checkpoint inhibition, 2022-08-03

• Investigating the Scope of Resident Patient Care Handoffs within Neurosurgery, 2012-07-27

• Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma, 2014-06-12

• Genomic landscape of gliosarcoma: distinguishing features and targetable alterations, 2021-09-09

• Eosinophil and lymphocyte counts predict bevacizumab response and survival in recurrent glioblastoma, 2020-03-11

• Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles, 2018-01-12

• Interfacility Helicopter Ambulance Transport of Neurosurgical Patients: Observations, Utilization, and Outcomes from a Quaternary Level Care Hospital, 2011-10-12

• Malpractice Liability and Defensive Medicine: A National Survey of Neurosurgeons, 2012-06-22

• The PROGRAM study: awake mapping versus asleep mapping versus no mapping for high-grade glioma resections: study protocol for an international multicenter prospective three-arm cohort study, 2021-07-21

• An integrative model of cellular states, plasticity and genetics for glioblastoma, 2019-07-18

• Reconstructing and reprogramming the tumor propagating potential of glioblastoma stem-like cells, 2014-04-10

• The Alliance AMBUSH Trial: Rationale and Design, 2022-01-14

• Cerebral edema and a transtentorial brain herniation syndrome associated with pandemic swine influenza A (H1N1) virus infection, 2011-07-13

• TERT promoter mutation analysis for blood-based diagnosis and monitoring of gliomas, 2020-10-13

• Socioeconomic Status Correlates with the Prevalence of Advanced Coronary Artery Disease in the United States, 2012-09-25

• Clinical features of brain metastasis from salivary gland tumors, 2013-05-16

• Radiation Treatment for WHO Grade II and III Meningiomas, 2013-09-02

• Sequestration of T-cells in bone marrow in the setting of glioblastoma and other intracranial tumors, 2018-08-13

• Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma, 2016-11-02

• Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage, 2014-06-18

• Brain Tumor Cells in Circulation are Enriched for Mesenchymal Gene Expression, 2014-08-19

• Neural encoding and production of functional morphemes in the posterior temporal lobe, 2018-05-14

• Surgical advances in the management of brain metastases, 2021-11-27

• Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq, 2017-03-31

• Deep brain stimulation for medically refractory life-threatening status dystonicus in children, 2013-07-25

• Laser interstitial thermal therapy for brain metastases, 2021-11-27

• Craniectomy for Malignant Cerebral Infarction: Prevalence and Outcomes in US Hospitals, 2011-12-14

• Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis, 2021-10-12